The clinical trials can make or break drug companies as their stock price reaction can either be overwhelmingly positive or brutal depending upon the trial results. Let's take a look at the biotech companies that are expected to report clinical trial results during the remainder of this month.
from RTT - Biotech http://ift.tt/2hbb0ge
via IFTTT
No comments:
Post a Comment